MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ*

Tamoxifen represents a major adjuvant therapy to those patients with estrogen receptor-alpha positive breast cancer. However, tamoxifen resistance occurs quite often, either de novo or acquired during treatment. To investigate the role of miR-320a in the development of resistance to tamoxifen, we es...

Descripción completa

Detalles Bibliográficos
Autores principales: Lü, Mingrong, Ding, Keshuo, Zhang, Guofeng, Yin, Mianmian, Yao, Guidong, Tian, Hui, Lian, Jie, Liu, Lin, Liang, Meng, Zhu, Tao, Sun, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348640/
https://www.ncbi.nlm.nih.gov/pubmed/25736597
http://dx.doi.org/10.1038/srep08735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348640/
https://www.ncbi.nlm.nih.gov/pubmed/25736597
http://dx.doi.org/10.1038/srep08735

Ejemplares similares